Tuesday, November 10, 2009

Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three Copaxone-Related Patents

Nov 10, 2009 - Teva Pharmaceutical Industries Ltd. announced today it is seeking to amend its existing complaint against Momenta Pharmaceuticals, Inc./Sandoz Inc. to include patent infringement of three additional patents related to the characterization of COPAXONE® (glatiramer acetate injection).

The details can be read here.

No comments: